Zurich Cantonal Bank’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.6M Sell
42,607
-6,981
-14% -$1.85M 0.04% 344
2026
Q1
$5.43M Buy
49,588
+16,613
+50% +$2.37M 0.01% 631
2025
Q4
$5.49M Buy
32,975
+7,142
+28% +$1.19M 0.01% 614
2025
Q3
$5.06M Buy
25,833
+1,628
+7% +$268K 0.01% 610
2025
Q2
$2.19M Buy
+24,205
New +$1.91M 0.01% 822
2025
Q1
– Sell
-10,416
Closed -$1.38M – 2690
2024
Q4
$1.38M Buy
+10,416
New +$978K ﹤0.01% 1038

Other funds holding ALAB

Zurich Cantonal Bank's ALAB Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Astera Labs (ALAB) stake by 14% in Q2 2026, selling an estimated $1.85M and leaving 42,607 shares worth $20.6M. The position accounts for 0.04% of the portfolio, ranked #344.

Zurich Cantonal Bank first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Zurich Cantonal Bank held 42,607 shares of Astera Labs worth $20.6M as of Q2 2026.
  • Zurich Cantonal Bank sold 6,981 Astera Labs shares in Q2 2026, an estimated $1.85M.
  • Astera Labs made up 0.04% of Zurich Cantonal Bank's portfolio in Q2 2026, its #344 holding.
  • Zurich Cantonal Bank first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.